Drug Approval | August 24, 2022
Merck gets fast track designation from the USFDA for anticoagulant therapy
Phase 2 Study of MK-2060 Currently Ongoing in People with End-Stage Renal Disease Receiving Hemodialysis
Phase 2 Study of MK-2060 Currently Ongoing in People with End-Stage Renal Disease Receiving Hemodialysis
The summit to demonstrate revolutionary techniques and advanced medical procedures for treating CTO
The approved product has an estimated market size of around US$ 606 million for the twelve months ending June 2022, according to IQVIA.
Use of IVUS recommended in all phases of lower extremity arterial and venous revascularization procedures to guide clinical decisions
Apollo Hospital Group completed the acquisition of a hospital asset in Gurugram for a consideration of around Rs 450 crore.
The two generic drugs have been launched under the brand names Jankey & Sitenali.
The expansion at CDMO facility in South Haven, will bring a new 4,000-gallon multi-use reactor train consisting of glass lined and stainless-steel materials of construction
An algorithm based testing for Fatty Liver Disease
Empagliflozin and Metformin Hydrochloride tablets are used with proper diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
The US FDA has determined that the inspection classification of the facility is Voluntary Action Indicated
Subscribe To Our Newsletter & Stay Updated
